Member Info for MrRSoul

Tucked up a treat IMO

666

Cauldstream7

This is not the first time such suspicions and confusion have been identified.

Have a read of Megans post a few days before 27th November I think it was around the 24th that Roger and I were discussing transactions.

You may find it helpful as I was not aware of such algorithm use.

The data stream from the London Stock Exchange which sites like this use doesn’t indicate whether a trade is a buy or a sell. This site uses an algorithm to make an educated guess about whether the trade was a buy or a sell. A trade above the mid price at the time it is printed is marked as a buy, below the mid price as a sell and exactly at the mid price as unknown. Delayed trades are also marked as unknown. Any trade marked as unknown is not included in the buy or sell totals. It is common for buys to be below the mid price and therefore marked as sells, or for sells to be above the mid price and therefore marked as buys. Daily buy and sell totals are based upon guesswork, not fact.

Rookie1

Interesting link...thankyou, and also for restoring some order to the board.

Halfbut

That delayed deal at 1552 looks dubious!!!

A little less conversation, a little more action please

All this aggravation ain't satisfactionin' me

A little more bite and a little less bark

A little less fight and a little more spark

Close your mouth and open up your heart and baby satisfy me

Satisfy me, Timmy satisfy me.

Oscar22

Uplifting positive post thankyou.

Now who is going to disagree with each point?

Professor1

I skimmed through it and don't recommend this as any read let alone bedtime read.......Scary eh?

Typo.... 'health'

Roger65

That moment to which you refer will be (according to you) only when the s.p. can be purchased at below 5 pence.

You now anticipate that to be 'at some pont next year'.

Please don't tell me and others that until that time ,you will continue to post on here your negative views on this stock/company.

To do so can only be construed as a concerted effort to persuade others not to invest and thereby have an adverse and deliberate affect on the s.p.

Will this stop if and when your predictions come true which allows you to buy in under 5 pence?

Give it rest Roger if only for your personal heath sake!

Oh Mardler you have made an inaccurate assumption.....Roger is not in!

NOW I see closing 6.17

Stout

I see 6.18

OSD

Please include 'Oh come all ye unfaithful'......that should raise attendance figures!

👍 👍

I know someone who has one of these every morning!

Msuk.int

Please continue with these posts I find them interesting.

For your information

This will mark the end of 20 years of market exclusivity during which AbbVie has earned nearly $200 billion from global sales of the drug.

Eight more biosimilars are expected to become available in 2023, putting AbbVie under pressure. Anticipating the competition, the company has spent the last few years trying to reduce its reliance on Humira, which, as recently as 2019, accounted for more than half of its revenue.

While pharmaceutical companies periodically face these “patent cliffs,” none has been steeper than the one AbbVie faces with Humira. Until now, the most lucrative product to become generic was Lipitor, Pfizer’s cholesterol-lowering drug, which at its peak sold around $13 billion annually. In 2021, Humira sales totaled $20.7 billion.

Roger65

45.73% in my case!

Just letting you know I'm not 'recycling you'.

JackB

My sentiments exactly.....respect.